225 related articles for article (PubMed ID: 16798034)
1. Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies.
Molfino NA; Jeffery PK
Pulm Pharmacol Ther; 2007; 20(5):462-72. PubMed ID: 16798034
[TBL] [Abstract][Full Text] [Related]
2. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
3. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD.
Morjaria JB; Malerba M; Polosa R
Drug Discov Today; 2010 May; 15(9-10):396-405. PubMed ID: 20223295
[TBL] [Abstract][Full Text] [Related]
4. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
5. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
6. Emerging drugs for chronic obstructive pulmonary disease.
Matera MG; Calzetta L; Segreti A; Cazzola M
Expert Opin Emerg Drugs; 2012 Mar; 17(1):61-82. PubMed ID: 22335427
[TBL] [Abstract][Full Text] [Related]
7. Emerging anti-inflammatory strategies for COPD.
Cazzola M; Page CP; Calzetta L; Matera MG
Eur Respir J; 2012 Sep; 40(3):724-41. PubMed ID: 22496331
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological treatment of COPD and future of anti-inflammatory therapy].
Watz H; Bitter-Suermann S; Kanniess F; Magnussen H
Med Klin (Munich); 2006 Apr; 101(4):283-92. PubMed ID: 16607484
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast for the treatment of chronic obstructive pulmonary disease.
Antoniu SA
Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
[TBL] [Abstract][Full Text] [Related]
10. New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.
Belvisi MG; Hele DJ; Birrell MA
Expert Opin Ther Targets; 2004 Aug; 8(4):265-85. PubMed ID: 15268623
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
McNamara PS; Smyth RL
Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
[TBL] [Abstract][Full Text] [Related]
12. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
[TBL] [Abstract][Full Text] [Related]
13. Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease.
Antoniu SA
Expert Opin Ther Targets; 2014 Nov; 18(11):1285-92. PubMed ID: 25213852
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.
Donnelly LE; Barnes PJ
Trends Pharmacol Sci; 2006 Oct; 27(10):546-53. PubMed ID: 16911834
[TBL] [Abstract][Full Text] [Related]
15. Chronic obstructive pulmonary disease in a new concept.
Murărescu ED; Mitrofan EC; Mihailovici MS
Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
17. COPD: is there light at the end of the tunnel?
Barnes PJ
Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418
[TBL] [Abstract][Full Text] [Related]
18. Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models.
Baker KE; Bonvini SJ; Donovan C; Foong RE; Han B; Jha A; Shaifta Y; Smit M; Johnson JR; Moir LM
Pulm Pharmacol Ther; 2014 Dec; 29(2):181-98. PubMed ID: 24929072
[TBL] [Abstract][Full Text] [Related]
19. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development.
Fitzgerald MF; Fox JC
Drug Discov Today; 2007 Jun; 12(11-12):479-86. PubMed ID: 17532533
[TBL] [Abstract][Full Text] [Related]
20. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma.
Sutherland ER; Martin RJ
J Allergy Clin Immunol; 2003 Nov; 112(5):819-27; quiz 828. PubMed ID: 14610463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
